Home
>
Assessments
>
Use of Genetic Testing to Guide the Initiation of Warfarin Therapy
Use of Genetic Testing to Guide the Initiation of Warfarin Therapy
| Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered. |
| Review Date: |
March 5, 2008 |
| Recommendation: |
This topic was reviewed by the California Technology Assessment Forum on March 5, 2008.
It was recommended that the use of genetic testing to guide initial warfarin dosing does not meet Technology Assessment Criteria 3 through 5 for safety, effectiveness and improvement in health outcomes. |
| Decision: |
Does Not Meet CTAF Criteria |
| Full Assessment: |
Download (PDF) |
|
|
© 2010 California Technology Assessment Forum. All rights reserved.
